Demand for disinfectant in the medical field and the health sector has grown due to the spread of coronavirus. In order to avoid supply shortages, the Siegfried Group (SIX: SFZN) decided to actively support the health sector with the supply of disinfectant in those regions in which the Group operates production sites. The service including delivery is free of charge to the extent possible. In Switzerland, consignments have been shipped in Canton Aargau, while shipment in Canton Valais is imminent. At the Minden site in Germany, regional health organizations have already been taken care of. Siegfried is in close contact with the authorities at the locations of its other production sites. Siegfried will not supply private or commercial organizations.
The Siegfried Group is a global life sciences company with sites in Switzerland, the USA, Malta, China, Germany and France. In 2019, the company achieved sales of 833.5 million Swiss francs and currently employs about 2500 people at nine sites on three continents. Siegfried Holding AG is publicly listed on SIX Swiss Exchange (SIX: SFZN).
Siegfried is active in manufacturing pharmaceutical APIs (and their intermediates) as well as drug products (tablets, capsules, sterile vials, ampoules, and cartridges) for the pharmaceutical industry and provides development services.